Legal & General Group Plc - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3,110,836
-59.4%
81,778
-2.8%
0.00%
-50.0%
Q2 2023$7,666,157
+34.1%
84,151
-2.9%
0.00%0.0%
Q1 2023$5,716,620
+37.5%
86,668
+7.8%
0.00%0.0%
Q4 2022$4,157,173
-24.5%
80,394
-0.3%
0.00%0.0%
Q3 2022$5,508,000
+48.6%
80,642
-1.6%
0.00%
+100.0%
Q2 2022$3,707,000
+3.7%
81,974
+16.5%
0.00%0.0%
Q1 2022$3,575,000
+9.3%
70,357
+1.7%
0.00%0.0%
Q4 2021$3,270,000
+71.4%
69,167
+19.5%
0.00%0.0%
Q3 2021$1,908,000
-33.9%
57,899
+26.7%
0.00%0.0%
Q2 2021$2,888,000
+49.3%
45,707
+1.4%
0.00%0.0%
Q1 2021$1,935,000
-25.1%
45,097
-0.2%
0.00%0.0%
Q4 2020$2,583,000
+113.3%
45,167
+12.6%
0.00%0.0%
Q3 2020$1,211,000
+78.6%
40,130
+93.5%
0.00%
Q2 2020$678,000
+106.1%
20,743
+78.7%
0.00%
Q1 2020$329,000
-13.2%
11,607
-6.2%
0.00%
Q4 2019$379,000
+50.4%
12,373
+18.1%
0.00%
Q3 2019$252,000
-4.9%
10,4760.0%0.00%
Q2 2019$265,000
+64.6%
10,476
+27.3%
0.00%
Q1 2019$161,000
+87.2%
8,229
+27.1%
0.00%
Q4 2018$86,000
-20.4%
6,475
+7.2%
0.00%
Q3 2018$108,000
-8.5%
6,038
+12.1%
0.00%
Q2 2018$118,000
+181.0%
5,385
+186.1%
0.00%
Q1 2018$42,000
+2.4%
1,8820.0%0.00%
Q4 2017$41,0001,8820.00%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders